Event Highlights
Join in 2023 to:
Understand the key preclinical stages that
helped supercharge the first clinical candidate for RNA editing towards the clinic to help accelerate your own pipeline Wave Life Sciences
Explore the recent advancements in delivering the RNA editing machinery to target cells to minimize off target effects with Sapreme Technologies & Nebraska Medical Center
Harness the power of machine learning & data models to elevate the efficiency & selectivity of RNA editing to enable more accurate target discovery with Shape Therapeutics, Korro Bio
& Arrakis Therapeutics
Discover the impact of chemical modifications
& synthetic biology tools on the potency of RNA editing oligonucleotides to improve durability & efficiency with ProQR & MIT
Understand how RNA editing technologies such as ADAR, APOBEC, exon editing & splice switching of oligonucleotides influence delivery, gene activation & downregulation in rare disease with Ascidian Therapeutics, QurAlis, Feldan Therapeutics & MiNA Therapeutics
Download the Full Event Guide to see the full scope of content and speakers.
New Sessions You Cannot Miss:
Gain unmissable insights with a cross-discipline speaker faculty of 26+ global RNA experts, including but not limited to:
The First Clinical Candidate for RNA Editing
Prashant Monian
Senior Scientist
Wave Life Sciences
Re-Engineering the Transcriptome via RNA Exon Editing: A Novel Therapeutic Approach
Daniel Rosan
Chief Business & Financial Officer
Ascidian Therapeutics
New Molecular Technologies for RNA Editing & Control
Jonathan Gootenberg Omar Abuddayyeh
McGovern Fellow McGovern Fellow
MIT MIT
Using Machine Learning for Structural Design and Optimization of Chemically Modified Guide RNAs to Maximize Editing Efficacy
Mateusz Maciejewki
Vice President & Head of Data Science
Korro Bio
